Newsroom
  • July 13 , 2020

    Cancer Stakeholders Call for Consensus of Terms to Encourage Patients’ Genetic Testing

    Read more
  • July 13 , 2020

    Coronavirus vaccine update: Bharat Biotech starts human trials; Russia successfully completes human testing

    As global efforts are on to develop a safe and affordable COVID-19 vaccine, the big question remains unanswered: When will it be ready? India, which is only behind the United States and Brazil in coronavirus numbers, is also quickening up its pace to find a potent drug as early as possible. However, since the Centre is yet to announce a national policy on CO
    Read more
  • July 13 , 2020

    Massachusetts biotech Revitope scores first collaboration thanks to dual-engaging T cell platform

    Revitope Oncology began 2020 hopeful that its cancer immunology platform would be finally ready to flourish. On Monday night, that platform nabbed the biotech its first collaboration.
    Read more
  • July 12 , 2020

    Takeda Provides Updates on Its Pharmacokinetic-guided Prophylaxis Studies at ISTH 2020, Reinforcing Its Commitment to Advancing Personalized Care for People with Bleeding Disorders

    The Data Demonstrating Benefits of Pharmacokinetic-Guided Prophylaxis Therapy in Hemophilia and von Willebrand Disease are Among 13 Presentations from Takeda’s Hematology Portfolio and Pipeline
    Read more
  • July 8 , 2020

    Contract Research Organization (CRO) Market in China 2020 Analysis to 2024 – Application, Emerging Trends and Leading Players

    China CRO market value is anticipated to reach US$27.04 billion in 2024, growing at a CAGR of 27.06%, for the period spanning from 2020 to 2024.
    Read more
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us